Download PDF
Aktuelle Kardiologie 2025; 14(01): 21-27
DOI: 10.1055/a-2462-4529
Kurzübersicht

TAVI: Ist das Verfahren eine Alternative bei Patienten ohne erhöhtes Operationsrisiko?

TAVI: A Valid Option for Patients Without Increased Surgical Risk?
Daniel Strohleit
1   Klinik für Kardiologie und Angiologie, BG Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Deutschland
,
Moritz Seiffert 
1   Klinik für Kardiologie und Angiologie, BG Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Die kathetergestützte Aortenklappenimplantation (TAVI) hat sich als sichere und effektive Prozedur zur Behandlung der hochgradigen symptomatischen Aortenklappenstenose etabliert und wird mittlerweile auch bei Patienten niedrigen und intermediären Risikos eingesetzt. Die verfügbaren Studien hierzu umfassen mittlerweile mehr als 9000 Patienten mit sehr vielversprechenden Ergebnissen für das kathetergestützte Verfahren im Vergleich mit dem operativen Aortenklappenersatz. Inwieweit sich diese Ergebnisse auch über einen langfristigen Nachbeobachtungszeitraum bestätigen, bleibt derzeit noch abzuwarten. Auch darüber hinaus wird das interdisziplinäre Herzteam integraler Bestandteil der Indikationsstellung und Therapieplanung bleiben.

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved as a safe and effective treatment option for patients with severe symptomatic aortic stenosis and is increasingly being performed in low-risk patients. Data from randomized trials including more than 9000 patients demonstrate very promising outcomes after TAVI compared to surgical aortic valve replacement in this patient population. If these positive results sustain over long-term follow-up remains to be determined. Above all, the interdisciplinary heart team remains of paramount importance for decisions on treatment strategies in these patients with severe aortic stenosis.

Was ist wichtig?

  • In der Behandlung der hochgradigen Aortenklappenstenose zeigt sich die kathetergestützte Aortenklappenimplantation (TAVI) dem Aortenklappenersatz (AKE) bei Patienten mit niedrigem und intermediärem operativem Risiko über den bislang untersuchten Beobachtungszeitraum bei geringerer Invasivität mindestens ebenbürtig, unter bestimmten Aspekten sogar überlegen.

  • Insbesondere Langzeitdaten von Studien aus der klinischen Praxis sind noch erforderlich, um offene Fragen zur Durchführung der TAVI in einem jüngeren Niedrigrisiko-Kollektiv abschließend zu beantworten.

  • Das interdisziplinäre Herzteam bleibt integraler Bestandteil der Indikationsstellung und Therapieplanung im Sinne eines auf den Patienten individuell zugeschnittenen Behandlungskonzepts.

Schlüsselwörter

Aortenklappenstenose - TAVI - AKE

Keywords

TAVI - TAVR - SAVR - aortic stenosis


Publication History

Article published online:
05 February 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Thaden JJ, Nkomo VT, Enriquez-Sarano M. The Global Burden of Aortic Stenosis. Prog Cardiovasc Dis 2014; 56: 565-571
    CrossrefPubMedSearch in Google Scholar
  • 2 Adams DH, Popma JJ, Reardon MJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med 2014; 370: 1790-1798
    CrossrefPubMedSearch in Google Scholar
  • 3 Smith CR, Leon MB, Mack MJ. et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med 2011; 364: 2187-2198
    CrossrefPubMedSearch in Google Scholar
  • 4 Gleason TG, Reardon MJ, Popma JJ. et al. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol 2018; 72: 2687-2696
    CrossrefPubMedSearch in Google Scholar
  • 5 Mack MJ, Leon MB, Smith CR. et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477-2484
    CrossrefPubMedSearch in Google Scholar
  • 6 Kapadia SR, Leon MB, Makkar RR. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485-2491
    CrossrefPubMedSearch in Google Scholar
  • 7 Leon MB, Smith CR, Mack M. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607
    CrossrefPubMedSearch in Google Scholar
  • 8 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2022; 43: 561-632
    CrossrefPubMedSearch in Google Scholar
  • 9 Otto CM, Nishimura RA, Bonow RO. et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e72-e227
    CrossrefPubMedSearch in Google Scholar
  • 10 Shahian DM, Jacobs JP, Badhwar V. et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1—Background, Design Considerations, and Model Development. Ann Thorac Surg 2018; 105: 1411-1418
    CrossrefPubMedSearch in Google Scholar
  • 11 Nashef SA, Roques F, Sharples LD. et al. Euroscore ii. Eur J Cardiothorac Surg 2012; 41: 734-745
    CrossrefPubMedSearch in Google Scholar
  • 12 Thyregod HGH, Jørgensen TH, Ihlemann N. et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024; 45: 1116-1124
    CrossrefPubMedSearch in Google Scholar
  • 13 Thyregod HGH, Steinbrüchel DA, Ihlemann N. et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015; 65: 2184-2194
    CrossrefPubMedSearch in Google Scholar
  • 14 Jørgensen TH, Thyregod HGH, Ihlemann N. et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021; 42: 2912-2919
    CrossrefPubMedSearch in Google Scholar
  • 15 Leon MB, Smith CR, Mack MJ. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-1620
    CrossrefPubMedSearch in Google Scholar
  • 16 Reardon MJ, Van Mieghem NM, Popma JJ. et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017; 376: 1321-1331
    CrossrefPubMedSearch in Google Scholar
  • 17 Van Mieghem NM, Deeb GM, Søndergaard L. et al. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA Cardiol 2022; 7: 1000-1008
    CrossrefPubMedSearch in Google Scholar
  • 18 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1695-1705
    CrossrefPubMedSearch in Google Scholar
  • 19 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med 2023; 389: 1949-1960
    CrossrefPubMedSearch in Google Scholar
  • 20 Forrest JK, Deeb GM, Yakubov SJ. et al. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. J Am Coll Cardiol 2023; 82: 2163-2165
    CrossrefPubMedSearch in Google Scholar
  • 21 Popma JJ, Deeb GM, Yakubov SJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1706-1715
    CrossrefPubMedSearch in Google Scholar
  • 22 Toff WD, Hildick-Smith D, Kovac J. UK TAVI Trial Investigators. et al. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA 2022; 327: 1875-1887
    CrossrefPubMedSearch in Google Scholar
  • 23 Blankenberg S, Seiffert M, Vonthein R. et al. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med 2024; 390: 1572-1583
    CrossrefPubMedSearch in Google Scholar
  • 24 Jørgensen TH, Thyregod HGH, Savontaus M. et al. Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial. Eur Heart J 2024; 45: 3804-3814
    CrossrefPubMedSearch in Google Scholar
  • 25 Ahmad Y, Howard JP, Arnold AD. et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J 2023; 44: 836-852
    CrossrefPubMedSearch in Google Scholar
  • 26 Rahman H, Ghosh P, Nasir F. et al. Short- and intermediate-term outcomes of transcatheter aortic valve replacement in low-risk patients: A meta-analysis and systematic review. Int J Cardiol Heart Vasc 2024; 53: 101458
    CrossrefPubMedSearch in Google Scholar
  • 27 Kolkailah A, Doukky R, Pelletier M. et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev 2019; (12) CD013319
    CrossrefPubMedSearch in Google Scholar
  • 28 Ahmed K, McVeigh T, Cerneviciute R. et al. Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis. BMC Nephrol 2018; 19: 323
    CrossrefPubMedSearch in Google Scholar
  • 29 Bruno F, D’Ascenzo F, Vaira MP. et al. Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis. Eur Heart J Qual Care Clin Outcomes 2021; 7: 143-153
    CrossrefPubMedSearch in Google Scholar
  • 30 Di Pietro G, Improta R, De Filippo O. et al. Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients: An Updated Metanalysis of Extended Follow-Up Randomized Controlled Trials. Am J Cardiol 2024; 224: 56-64
    CrossrefPubMedSearch in Google Scholar
  • 31 O’Hair D, Yakubov SJ, Grubb KJ. et al. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. JAMA Cardiol 2023; 8: 111-119
    CrossrefPubMedSearch in Google Scholar